An inventive cancer care startup, Oncare has lifted $1 million in its seed funding round from Huddle Ventures.

Prominent institutional Venture Capitalists including Cloud Capital, DeVC, and TRTL Ventures also participated in the funding round.

Over the following two years, the startup plans to use the revenues to grow to ten new locations around Delhi NCR, Bangalore, and Jaipur.

The money raised in a funding round will also go into growing the team and promoting the brand's reasonably priced cancer care options through marketing campaigns.

Oncare, which was founded in the year 2023 by Deepak Kumar and Amar Sneh, is collaborating with hospitals that have 50–100 beds to establish oncology wards.

By means of these collaborations, Oncare is able to lower treatment expenses by up to 40%.

The firm says it provides a high-quality, reasonably priced substitute for costly cancer treatments, which can cost up to Rs 10 lakh in corporate hospitals.

Additionally, it provides patients with on-call nurse care to help them deal with the disputes and side effects of cancer therapies without needing to make unneeded hospital trips.

Over the course of its ten months of operation, the South Delhi firm has guided over 2,500 patients with their treatment plans and claims to have completed over 500 treatment sessions.

The annual Health of Nation report from Apollo Hospitals indicates that India has an alarmingly high cancer burden, with 1.39 million cases projected in 2020 and 1.57 million cases annually by 2025.

However, millions of people cannot afford cancer care due to exorbitant treatment costs, a lack of oncology centers, and a shortage of specialized personnel.